Last update 21 Nov 2024
anti-GPC3 CAR T(Shanghai Renji Hospital)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type CAR-T |
Synonyms- |
Target |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with anti-GPC3 CAR T(Shanghai Renji Hospital)Clinical Study of Redirected Autologous T Cells With a GPC3-targeted Chimeric Antigen Receptor in Patients With Refractory Hepatocellular Carcinoma
Autologous T Cells Redirected to GPC3 for Treating Patients With Advanced HCC
100 Clinical Results associated with anti-GPC3 CAR T(Shanghai Renji Hospital)
Login to view more data
100 Translational Medicine associated with anti-GPC3 CAR T(Shanghai Renji Hospital)
Login to view more data
100 Patents (Medical) associated with anti-GPC3 CAR T(Shanghai Renji Hospital)
Login to view more data
100 Deals associated with anti-GPC3 CAR T(Shanghai Renji Hospital)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatocellular Carcinoma | Phase 1 | CN | 01 Mar 2015 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
NCT02395250 (Literature) Manual  | Phase 1 | 2 | (fahiuwwsss) = For case 1: overall survival time more than 8 years; For case 2: disease-free for more than 5 years without any further anticancer treatment and has an overall survival time of over 8 years. ndspgjoxif (bmowbmxune ) | Positive | 21 Jul 2023 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free